NDC 68788-6394

Lamivudine and Zidovudine

Lamivudine And Zidovudine

Lamivudine and Zidovudine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Lamivudine; Zidovudine.

Product ID68788-6394_6c8bfd3c-831c-414a-9a71-a20d22e48028
NDC68788-6394
Product TypeHuman Prescription Drug
Proprietary NameLamivudine and Zidovudine
Generic NameLamivudine And Zidovudine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-05-24
Marketing CategoryANDA / ANDA
Application NumberANDA079128
Labeler NamePreferred Pharmaceuticals Inc.
Substance NameLAMIVUDINE; ZIDOVUDINE
Active Ingredient Strength150 mg/1; mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68788-6394-1

100 TABLET in 1 BOTTLE (68788-6394-1)
Marketing Start Date2016-05-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-6394-1 [68788639401]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-24

NDC 68788-6394-6 [68788639406]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-24

NDC 68788-6394-4 [68788639404]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-11

NDC 68788-6394-2 [68788639402]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-24

NDC 68788-6394-9 [68788639409]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-24

NDC 68788-6394-3 [68788639403]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-24

NDC 68788-6394-8 [68788639408]

Lamivudine and Zidovudine TABLET
Marketing CategoryANDA
Application NumberANDA079128
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-24

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE150 mg/1

OpenFDA Data

SPL SET ID:74f45eca-994a-4b12-af66-50ba77fe2065
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200082

    • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    NDC Crossover Matching brand name "Lamivudine and Zidovudine" or generic name "Lamivudine And Zidovudine"

    NDCBrand NameGeneric Name
    21695-996Lamivudine and ZidovudineLamivudine and Zidovudine
    31722-506LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    31722-739Lamivudine and ZidovudineLamivudine and Zidovudine
    33342-003Lamivudine and ZidovudineLamivudine and Zidovudine
    42291-363Lamivudine and ZidovudineLamivudine and Zidovudine
    43063-346Lamivudine and ZidovudineLamivudine and Zidovudine
    43063-900lamiVUDine and ZIDOVUDINElamiVUDine and ZIDOVUDINE
    50090-3920LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    50268-456LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    50436-0597Lamivudine and ZidovudineLamivudine and Zidovudine
    54741-102Lamivudine and Zidovudinelamivudine and zidovudine
    55700-096Lamivudine and ZidovudineLamivudine and Zidovudine
    57297-284LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    63629-4872Lamivudine and ZidovudineLamivudine and Zidovudine
    64380-707Lamivudine and ZidovudineLamivudine and Zidovudine
    65862-036Lamivudine and ZidovudineLamivudine and Zidovudine
    65862-597Lamivudine and ZidovudineLamivudine and Zidovudine
    68071-3311Lamivudine and ZidovudineLamivudine and Zidovudine
    68071-4450LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    68084-416Lamivudine and ZidovudineLamivudine and Zidovudine
    68180-284LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    68788-6394Lamivudine and ZidovudineLamivudine and Zidovudine
    68788-7298LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    69097-315Lamivudine and ZidovudineLamivudine and Zidovudine
    70518-0697Lamivudine and ZidovudineLamivudine and Zidovudine
    71335-0141Lamivudine and ZidovudineLamivudine and Zidovudine
    71335-0639LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    76519-1005Lamivudine and ZidovudineLamivudine and Zidovudine
    76282-115Lamivudine and ZidovudineLamivudine and Zidovudine
    72865-144LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    21695-846COMBIVIRlamivudine and zidovudine
    49702-202COMBIVIRlamivudine and zidovudine
    50090-0610COMBIVIRlamivudine and zidovudine
    52959-546COMBIVIRlamivudine and zidovudine
    53808-0895COMBIVIRlamivudine and zidovudine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.